Literature DB >> 9122260

Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity.

F K Hamra1, S L Eber, D T Chin, M G Currie, L R Forte.   

Abstract

Guanylin and uroguanylin are intestinal peptides that stimulate chloride secretion by activating a common set of receptor-guanylate cyclase signaling molecules located on the mucosal surface of enterocytes. High mucosal acidity, similar to the pH occurring within the fluid microclimate domain at the mucosal surface of the intestine, markedly enhances the cGMP accumulation responses of T84 human intestinal cells to uroguanylin. In contrast, a mucosal acidity of pH 5.0 renders guanylin essentially inactive. T84 cells were used as a model epithelium to further explore the concept that mucosal acidity imposes agonist selectivity for activation of the intestinal receptors for uroguanylin and guanylin, thus providing a rationale for the evolution of these related peptides. At an acidic mucosal pH of 5.0, uroguanylin is 100-fold more potent than guanylin, but at an alkaline pH of 8.0 guanylin is more potent than uroguanylin in stimulating intracellular cGMP accumulation and transepithelial chloride secretion. The relative affinities of uroguanylin and guanylin for binding to receptors on the mucosal surface of T84 cells is influenced dramatically by mucosal acidity, which explains the strong pH dependency of the cGMP and chloride secretion responses to these peptides. The guanylin-binding affinities for peptide-receptor interaction were reduced by 100-fold at pH 5 versus pH 8, whereas the affinities of uroguanylin for these receptors were increased 10-fold by acidic pH conditions. Deletion of the N-terminal acidic amino acids in uroguanylin demonstrated that these residues are responsible for the increase in binding affinities that are observed for uroguanylin at acidic pH. We conclude that guanylin and uroguanylin evolved distinctly different structures, which enables both peptides to regulate, in a pH-dependent fashion, the activity of receptors that control intestinal salt and water transport via cGMP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122260      PMCID: PMC20153          DOI: 10.1073/pnas.94.6.2705

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Autoradiographic demonstration of specific binding sites for E. coli enterotoxin in various epithelia of the North American opossum.

Authors:  W J Krause; R H Freeman; L R Fort
Journal:  Cell Tissue Res       Date:  1990-05       Impact factor: 5.249

2.  Vasoactive intestinal polypeptide-induced chloride secretion by a colonic epithelial cell line. Direct participation of a basolaterally localized Na+,K+,Cl- cotransport system.

Authors:  K Dharmsathaphorn; K G Mandel; H Masui; J A McRoberts
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

3.  Opossum colonic mucosa contains uroguanylin and guanylin peptides.

Authors:  F K Hamra; W J Krause; S L Eber; R H Freeman; C E Smith; M G Currie; L R Forte
Journal:  Am J Physiol       Date:  1996-04

4.  Heat-stable enterotoxin of Escherichia coli: in vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine.

Authors:  M Field; L H Graf; W J Laird; P L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

5.  Uroguanylin: cloning of preprouroguanylin cDNA, mRNA expression in the intestine and heart and isolation of uroguanylin and prouroguanylin from plasma.

Authors:  X Fan; F K Hamra; R H Freeman; S L Eber; W J Krause; R W Lim; V M Pace; M G Currie; L R Forte
Journal:  Biochem Biophys Res Commun       Date:  1996-02-15       Impact factor: 3.575

Review 6.  Salt and water homeostasis: uroguanylin is a circulating peptide hormone with natriuretic activity.

Authors:  L R Forte; X Fan; F K Hamra
Journal:  Am J Kidney Dis       Date:  1996-08       Impact factor: 8.860

7.  Molecular structure of the toxin domain of heat-stable enterotoxin produced by a pathogenic strain of Escherichia coli. A putative binding site for a binding protein on rat intestinal epithelial cell membranes.

Authors:  H Ozaki; T Sato; H Kubota; Y Hata; Y Katsube; Y Shimonishi
Journal:  J Biol Chem       Date:  1991-03-25       Impact factor: 5.157

8.  Localization of acid microclimate along intestinal villi of rat jejunum.

Authors:  H Daniel; B Neugebauer; A Kratz; G Rehner
Journal:  Am J Physiol       Date:  1985-03

9.  Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device.

Authors:  R L Bown; J A Gibson; G E Sladen; B Hicks; A M Dawson
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

10.  Mechanism of action of Escherichia coli heat stable enterotoxin in a human colonic cell line.

Authors:  P A Huott; W Liu; J A McRoberts; R A Giannella; K Dharmsathaphorn
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

View more
  29 in total

Review 1.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

2.  Guanylin and functional coupling proteins in the hepatobiliary system of rat and guinea pig.

Authors:  Karen Schwabe; Yalcin Cetin
Journal:  Histochem Cell Biol       Date:  2012-02-07       Impact factor: 4.304

3.  Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.

Authors:  G M Pitari; M D Di Guglielmo; J Park; S Schulz; S A Waldman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

4.  A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.

Authors:  Michael A Valentino; Jieru E Lin; Adam E Snook; Peng Li; Gilbert W Kim; Glen Marszalowicz; Michael S Magee; Terry Hyslop; Stephanie Schulz; Scott A Waldman
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

5.  Role of the prosequence of guanylin.

Authors:  A Schulz; U C Marx; Y Hidaka; Y Shimonishi; P Rösch; W G Forssmann; K Adermann
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

6.  Taking a lesson from microbial diarrheagenesis in the management of chronic constipation.

Authors:  Adil E Bharucha; Scott A Waldman
Journal:  Gastroenterology       Date:  2010-01-27       Impact factor: 22.682

7.  Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single doses.

Authors:  Kunwar Shailubhai; Stephen Comiskey; John A Foss; Rong Feng; Laura Barrow; Gail M Comer; Gary S Jacob
Journal:  Dig Dis Sci       Date:  2013-04-27       Impact factor: 3.199

8.  Receptor guanylyl cyclase C (GC-C): regulation and signal transduction.

Authors:  Nirmalya Basu; Najla Arshad; Sandhya S Visweswariah
Journal:  Mol Cell Biochem       Date:  2009-12-04       Impact factor: 3.396

9.  A novel role for uroguanylin in the regulation of sodium balance.

Authors:  Leonard R Forte
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

10.  Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide.

Authors:  Nicholas G Moss; Robert C Fellner; Xun Qian; Sharon J Yu; Zhiping Li; Masamitsu Nakazato; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.